Alpha Tau Medical (NASDAQ: DRTSW) submits H1 2025 interim financial statements

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. filed a Form 6-K furnishing its interim consolidated financial statements as of June 30, 2025 and an operating and financial review for the six months ended June 30, 2025. These documents, plus an August 11, 2025 press release, are incorporated by reference into multiple existing Form F-3 and Form S-8 registration statements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 08/11/2025 - 04:03 PM Learn about SEC filing dates

FAQ

What did Alpha Tau Medical Ltd. (DRTSW) file in its August 2025 Form 6-K?

Alpha Tau Medical Ltd. filed a Form 6-K furnishing interim consolidated financial statements as of June 30, 2025, an operating and financial review for the six-month period ended June 30, 2025, and a press release dated August 11, 2025, along with related XBRL data.

Which financial periods are covered in Alpha Tau Medical Ltd.’s June 30, 2025 interim statements?

The interim consolidated financial statements cover Alpha Tau Medical Ltd.’s financial position as of June 30, 2025 and December 31, 2024, and include results for the six months ended June 30, 2025 and 2024, with balance sheets, operations, equity changes, cash flows, and accompanying notes presented in XBRL format.

How is the August 2025 Form 6-K of Alpha Tau Medical Ltd. used in its registration statements?

The interim financial statements and operating and financial review attached to Alpha Tau Medical Ltd.’s Form 6-K are incorporated by reference into its existing Form F-3 and Form S-8 registration statements, effectively updating those registration documents with the most recent mid‑year financial and narrative information.

What exhibits are included with Alpha Tau Medical Ltd.’s August 2025 Form 6-K?

The Form 6-K includes Exhibit 99.1 with interim consolidated financial statements, Exhibit 99.2 with the operating and financial review, Exhibit 99.3 containing a press release dated August 11, 2025, and Exhibit 101 and 104 providing XBRL-formatted financial data and the cover page interactive data file.

Who signed Alpha Tau Medical Ltd.’s August 11, 2025 Form 6-K filing?

The Form 6-K for Alpha Tau Medical Ltd. dated August 11, 2025 was signed on behalf of the company by Uzi Sofer, who is identified in the document as the Chief Executive Officer, confirming the company’s authorization of the submission.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025 

Commission File Number: 001-41316

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its Charter)

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

CONTENTS

The following documents are attached hereto:

● Exhibit 99.1. Interim Consolidated Financial Statements as of June 30, 2025.

● Exhibit 99.2. Operating and Financial Review and Prospects in connection the Interim Consolidated Financial Statements for the six months ended June 30, 2025.

● Exhibit 99.3. Press Release dated August 11, 2025

The Interim Consolidated Financial Statements of Alpha Tau Medical Ltd. as of June 30, 2025 attached as Exhibit 99.1 and the Operating Results and Financial Review in connection with the Interim Consolidated Financial Statements of Alpha Tau Medical Ltd. for the six months ended June 30, 2025 attached as Exhibit 99.2 to this Report on Form 6-K are hereby incorporated by reference into the registrant’s Registration Statements on Form F-3 (File Nos. 333-271073, 333-264306, 333-274457 and 333-288240) and Form S-8 (File Nos. 333-264169, 333-270406, 333-277733 and 333-285745).

1

EXHIBIT INDEX

Exhibit No.		Description
99.1		Interim Consolidated Financial Statements as of June 30, 2025.
99.2		Operating and Financial Review and Prospects in connection the Interim Consolidated Financial Statements for the six months ended June 30, 2025.
99.3		Press Release dated August 11, 2025
101		The following financial information from Alpha Tau Medical Ltd.’s Report on Form 6-K, formatted in XBRL (eXtensible Business Reporting Language): (i) Interim Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024; (ii) Interim Consolidated Statements of Operations for the six months ended June 30, 2025 and 2024; (iii) Interim Consolidated Statements of Changes in Shareholders’ Equity for the six months ended June 30, 2025 and 2024; (iv) Interim Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 2024; and (v) Notes to the Interim Consolidated Financial Statements.
104		Cover Page Interactive Data File (embedded within the inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alpha Tau Medical Ltd.
Date: August 11, 2025	By:	/s/ Uzi Sofer
		Uzi Sofer
		Chief Executive Officer

3